# InnovAge Holding Corp. (INNV) · Edgar & Edgarette company card

> InnovAge Holding (INNV) grew revenue 15.9% in FY2026 to $990 million, operating margin 0.3% against a -3.3% median for health services, equity 42.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1834376 · fiscal year ended 2026-06-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/INNV) · [JSON](https://www.pops4.com/boards/company/INNV.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $990M |
| Revenue growth, 1 year | 15.9% |
| Revenue growth per year | 9.1% |
| Operating margin | 0.3% (prior year -3.5%) |
| Net margin | -0.3% |
| Operating cash flow | $65M |
| Capital spending | $14M |
| Free cash flow | $50M |
| Cash | $98M |
| Long-term debt | $49M |
| Total assets | $557M |
| Total equity | $236M |
| Equity ÷ assets | 42.3% |
| Return on equity | -1.1% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 0.39 (distress zone)
- Piotroski F: 7 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $989.7M (FY2026), total debt $48.8M. Experience: revenue up 15.9% on the year, up 9.1% a year over 4 years; operating margin 0.3%, up from -3.5%. Soundness: equity 42.3% of assets, return on equity -1.1%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $970.8M and $1.3B next year (method v4.1: its own 5-year record of growth weighed at 57% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $907.5M to $1.4B. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, services-health services): operating margin 0.3% against a -3.3% median; growth 15.9% against 19.2%.

Range logged 2026-09-24, receipt 3c89f13f8a3ea4e1, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-05-12 ([filing](https://www.sec.gov/Archives/edgar/data/1834376/000183437626000025/0001834376-26-000025-index.htm))

## Recent filings

- 10-Q · filed 2026-11-03 · [filing](https://www.sec.gov/Archives/edgar/data/1834376/000183437626000054/0001834376-26-000054-index.htm)
- 8-K · filed 2026-11-03 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1834376/000183437626000052/0001834376-26-000052-index.htm)
- DEF 14A · filed 2026-10-22 · [filing](https://www.sec.gov/Archives/edgar/data/1834376/000114036126040511/0001140361-26-040511-index.htm)
- 8-K · filed 2026-09-24 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1834376/000110465926110388/0001104659-26-110388-index.htm)
- 10-K · filed 2026-09-09 · [filing](https://www.sec.gov/Archives/edgar/data/1834376/000183437626000049/0001834376-26-000049-index.htm)
- 8-K · filed 2026-09-08 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1834376/000183437626000047/0001834376-26-000047-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001834376.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1834376

## Cite

POPS4, Edgar & Edgarette: InnovAge Holding Corp. (INNV) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/INNV. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.